Niccolo Candelise
Overview
Explore the profile of Niccolo Candelise including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
453
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manganelli V, Costanzo M, Caissutti D, Salvatori I, Candelise N, Montalesi E, et al.
Sci Rep
. 2025 Mar;
15(1):7642.
PMID: 40038411
Neuroglobin (NGB) is a hexacoordinated hemeprotein mainly expressed in neurons. Following its upregulation and mitochondrial localization, NGB plays a pro-survival role against neuronal stress. Previously, we built a stable NGB-FLAG-overexpressing...
2.
Santilli F, Fabrizi J, Santacroce C, Caissutti D, Spinello Z, Candelise N, et al.
Stem Cell Rev Rep
. 2023 Nov;
20(1):159-174.
PMID: 37962698
Mesenchymal stem cells (MSCs) are well known for their beneficial effects, differentiation capacity and regenerative potential. Dental-derived MSCs (DSCs) are more easily accessible and have a non-invasive isolation method rather...
3.
Candelise N, Caissutti D, Zenuni H, Nesci V, Scaricamazza S, Salvatori I, et al.
Mol Neurobiol
. 2023 Jul;
60(11):6346-6361.
PMID: 37450246
The TAR-DNA binding protein (TDP43) is a nuclear protein whose cytoplasmic inclusions are hallmarks of Amyotrophic Lateral Sclerosis (ALS). Acute stress in cells causes TDP43 mobilization to the cytoplasm and...
4.
Candelise N, Santilli F, Fabrizi J, Caissutti D, Spinello Z, Moliterni C, et al.
Cells
. 2023 Jul;
12(13).
PMID: 37443720
Despite decades of research, no therapies are available to halt or slow down the course of neuro-degenerative disorders. Most of the drugs developed to fight neurodegeneration are aimed to alleviate...
5.
Schmitz M, Candelise N, Canaslan S, Altmeppen H, Matschke J, Glatzel M, et al.
Transl Neurodegener
. 2023 Mar;
12(1):12.
PMID: 36915212
α-Synucleinopathies, such as Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy, are a class of neurodegenerative diseases exhibiting intracellular inclusions of misfolded α-synuclein (αSyn), referred to...
6.
Zenuni H, Candelise N, Grillo P, Simonetta C, Bovenzi R, Ferri A, et al.
J Integr Neurosci
. 2022 Nov;
21(6):165.
PMID: 36424753
Background: Monoamine oxidase type B inhibitors (iMAO-Bs) are a class of largely-used antiparkinsonian agents that, based on experimental evidence, are supposed to exert different degrees of neuroprotection in Parkinson's disease...
7.
Candelise N, Salvatori I, Scaricamazza S, Nesci V, Zenuni H, Ferri A, et al.
Metabolites
. 2022 Mar;
12(3).
PMID: 35323676
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive loss of the upper and lower motor neurons. Despite the increasing effort in understanding the etiopathology of ALS,...
8.
Scaricamazza S, Salvatori I, Amadio S, Nesci V, Torcinaro A, Giacovazzo G, et al.
Br J Pharmacol
. 2021 Nov;
179(8):1732-1752.
PMID: 34783031
Background And Purpose: Amyotrophic lateral sclerosis (ALS), a neurodegenerative disease characterized by the degeneration of upper and lower motor neurons, progressive wasting and paralysis of voluntary muscles and is currently...
9.
Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C, et al.
NPJ Parkinsons Dis
. 2021 Oct;
7(1):93.
PMID: 34635674
Neurofilament light chain (NfL) and α-synuclein oligomeric seeds (α-syn-s) are promising biomarkers for patients with parkinsonism. We assessed their performance in discriminating Parkinson disease (PD) from atypical parkinsonisms (APDs) and...
10.
Candelise N, Scaricamazza S, Salvatori I, Ferri A, Valle C, Manganelli V, et al.
Int J Mol Sci
. 2021 Jul;
22(11).
PMID: 34199513
Intrinsic disorder is a natural feature of polypeptide chains, resulting in the lack of a defined three-dimensional structure. Conformational changes in intrinsically disordered regions of a protein lead to unstable...